866-997-4948(US-Canada Toll Free)

Global Biologics and Biosimilars Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 122 Pages

This report studies the global market size of Biologics and Biosimilars in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biologics and Biosimilars in these regions.
This research report categorizes the global Biologics and Biosimilars market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.
Most of biologics manufacturer are concentrated in US, Germany,UK and other developed countries. But in biosimilars industry the situation is different, manufacturer in developing countries play a very important role.
Through the research we tend to believe that the growth of biologics industry maybe slow but high profits during the period of patent may attractive. As to biosimilars, now is a changce for newcomers and they will greatly change the industry.

In 2017, the global Biologics and Biosimilars market size was 209400 million US$ and is forecast to 297100 million US in 2025, growing at a CAGR of 4.5% from 2018. The objectives of this study are to define, segment, and project the size of the Biologics and Biosimilars market based on company, product type, application and key regions.

The various contributors involved in the value chain of Biologics and Biosimilars include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Biologics and Biosimilars include
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee

Market Size Split by Type
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Market Size Split by Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Biologics and Biosimilars market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Biologics and Biosimilars market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Biologics and Biosimilars manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biologics and Biosimilars with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Biologics and Biosimilars submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biologics and Biosimilars are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biologics and Biosimilars market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Biologics and Biosimilars Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Biologics and Biosimilars Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Interferon
1.4.4 Erythropoietin
1.4.5 Insulin
1.4.6 Vaccines
1.4.7 Other
1.5 Market by Application
1.5.1 Global Biologics and Biosimilars Market Size Growth Rate by Application
1.5.2 Tumor
1.5.3 Diabetes
1.5.4 Cardiovascular
1.5.5 Hemophilia
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Biologics and Biosimilars Market Size
2.1.1 Global Biologics and Biosimilars Revenue 2016-2025
2.1.2 Global Biologics and Biosimilars Sales 2016-2025
2.2 Biologics and Biosimilars Growth Rate by Regions
2.2.1 Global Biologics and Biosimilars Sales by Regions
2.2.2 Global Biologics and Biosimilars Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Biologics and Biosimilars Sales by Manufacturers
3.1.1 Biologics and Biosimilars Sales by Manufacturers
3.1.2 Biologics and Biosimilars Sales Market Share by Manufacturers
3.1.3 Global Biologics and Biosimilars Market Concentration Ratio (CR5 and HHI)
3.2 Biologics and Biosimilars Revenue by Manufacturers
3.2.1 Biologics and Biosimilars Revenue by Manufacturers (2016-2018)
3.2.2 Biologics and Biosimilars Revenue Share by Manufacturers (2016-2018)
3.3 Biologics and Biosimilars Price by Manufacturers
3.4 Biologics and Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 Biologics and Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biologics and Biosimilars Product Category
3.4.3 Date of International Manufacturers Enter into Biologics and Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Biologics and Biosimilars Sales by Type
4.2 Global Biologics and Biosimilars Revenue by Type
4.3 Biologics and Biosimilars Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Biologics and Biosimilars Breakdown Data by Application

6 North America
6.1 North America Biologics and Biosimilars by Countries
6.1.1 North America Biologics and Biosimilars Sales by Countries
6.1.2 North America Biologics and Biosimilars Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Biologics and Biosimilars by Type
6.3 North America Biologics and Biosimilars by Application
6.4 North America Biologics and Biosimilars by Company

7 Europe
7.1 Europe Biologics and Biosimilars by Countries
7.1.1 Europe Biologics and Biosimilars Sales by Countries
7.1.2 Europe Biologics and Biosimilars Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biologics and Biosimilars by Type
7.3 Europe Biologics and Biosimilars by Application
7.4 Europe Biologics and Biosimilars by Company

8 Asia Pacific
8.1 Asia Pacific Biologics and Biosimilars by Countries
8.1.1 Asia Pacific Biologics and Biosimilars Sales by Countries
8.1.2 Asia Pacific Biologics and Biosimilars Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Biologics and Biosimilars by Type
8.3 Asia Pacific Biologics and Biosimilars by Application
8.4 Asia Pacific Biologics and Biosimilars by Company

9 Central & South America
9.1 Central & South America Biologics and Biosimilars by Countries
9.1.1 Central & South America Biologics and Biosimilars Sales by Countries
9.1.2 Central & South America Biologics and Biosimilars Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Biologics and Biosimilars by Type
9.3 Central & South America Biologics and Biosimilars by Application
9.4 Central & South America Biologics and Biosimilars by Company

10 Middle East and Africa
10.1 Middle East and Africa Biologics and Biosimilars by Countries
10.1.1 Middle East and Africa Biologics and Biosimilars Sales by Countries
10.1.2 Middle East and Africa Biologics and Biosimilars Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Biologics and Biosimilars by Type
10.3 Middle East and Africa Biologics and Biosimilars by Application
10.4 Middle East and Africa Biologics and Biosimilars by Company

11 Company Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Biologics and Biosimilars
11.1.4 Biologics and Biosimilars Product Description
11.1.5 Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Biologics and Biosimilars
11.2.4 Biologics and Biosimilars Product Description
11.2.5 Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Biologics and Biosimilars
11.3.4 Biologics and Biosimilars Product Description
11.3.5 Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Biologics and Biosimilars
11.4.4 Biologics and Biosimilars Product Description
11.4.5 Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Biologics and Biosimilars
11.5.4 Biologics and Biosimilars Product Description
11.5.5 Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Biologics and Biosimilars
11.6.4 Biologics and Biosimilars Product Description
11.6.5 Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Biologics and Biosimilars
11.7.4 Biologics and Biosimilars Product Description
11.7.5 Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Biologics and Biosimilars
11.8.4 Biologics and Biosimilars Product Description
11.8.5 Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Biologics and Biosimilars
11.9.4 Biologics and Biosimilars Product Description
11.9.5 Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Biologics and Biosimilars
11.10.4 Biologics and Biosimilars Product Description
11.10.5 Recent Development
11.11 3sbio
11.12 Changchun High Tech
11.13 CP Guojian
11.14 Biotech
11.15 Gelgen
11.16 Innovent
11.17 Dong Bao
11.18 Ganlee

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Biologics and Biosimilars Raw Material
13.1.2 Biologics and Biosimilars Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Biologics and Biosimilars Production Market Share by Types (Product Category) in 2017
Figure Monoclonal Antibodies Product Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Interferon Product Picture
Table Major Manufacturers of Interferon
Figure Erythropoietin Product Picture
Table Major Manufacturers of Erythropoietin
Figure Insulin Product Picture
Table Major Manufacturers of Insulin
Figure Vaccines Product Picture
Table Major Manufacturers of Vaccines
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Biologics and Biosimilars Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Tumor
Figure Diabetes
Figure Cardiovascular
Figure Hemophilia
Figure Other
Figure Biologics and Biosimilars Report Years Considered
Figure Global Biologics and Biosimilars Market Size 2016-2025 (Million US$)
Figure Global Biologics and Biosimilars Sales 2016-2025 (K Units)
Table Global Biologics and Biosimilars Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Biologics and Biosimilars Sales by Regions 2016-2025 (K Units)
Table Global Biologics and Biosimilars Sales Market Share by Regions 2016-2025
Figure Global Biologics and Biosimilars Sales Market Share by Regions 2016-2025
Figure 2017 Global Biologics and Biosimilars Sales Market Share by Regions
Table Global Biologics and Biosimilars Revenue by Regions 2016-2025 (Million US$)
Table Global Biologics and Biosimilars Revenue Market Share by Regions 2016-2025
Figure Global Biologics and Biosimilars Revenue Market Share by Regions 2016-2025
Figure 2017 Global Biologics and Biosimilars Revenue Market Share by Regions
Table Global Biologics and Biosimilars Sales by Manufacturers (2016-2018) (K Units)
Table Global Biologics and Biosimilars Sales Share by Manufacturers (2016-2018)
Figure Global Biologics and Biosimilars Sales Share by Manufacturers in 2017
Table Biologics and Biosimilars Revenue by Manufacturers (2016-2018) (Million US$)
Table Biologics and Biosimilars Revenue Share by Manufacturers (2016-2018)
Figure Biologics and Biosimilars Value Share by Manufacturers in 2017
Table Global Biologics and Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Biologics and Biosimilars Price (2016-2018) (USD/Unit)
Table Biologics and Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Biologics and Biosimilars Product Category
Table Date of International Manufacturers Enter into Biologics and Biosimilars Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Biologics and Biosimilars Sales by Type (2016-2025) (K Units)
Table Global Biologics and Biosimilars Sales Share by Type (2016-2025)
Figure Global Biologics and Biosimilars Sales Market Share by Type (2016-2025)
Figure Global Biologics and Biosimilars Sales Market Share by Type in 2017
Table Global Biologics and Biosimilars Revenue by Type (2016-2025) (Million US$)
Table Global Biologics and Biosimilars Revenue Share by Type (2016-2025)
Figure Global Biologics and Biosimilars Revenue Market Share by Type (2016-2025)
Figure Global Biologics and Biosimilars Revenue Market Share by Type in 2017
Table Biologics and Biosimilars Price by Type 2013-2018 (USD/Unit)
Table Global Biologics and Biosimilars Sales by Application (2016-2025) (K Units)
Table Global Biologics and Biosimilars Sales Share by Application (2016-2025)
Figure Global Sales Biologics and Biosimilars Market Share by Application (2016-2025)
Figure Global Sales Biologics and Biosimilars Market Share by Application (2016-2025)
Figure North America Biologics and Biosimilars Sales Growth Rate 2016-2025 (K Units)
Figure North America Biologics and Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table North America Biologics and Biosimilars Sales by Countries (2016-2025) (K Units)
Table North America Biologics and Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 North America Biologics and Biosimilars Sales Market Share by Countries
Table North America Biologics and Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table North America Biologics and Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Biologics and Biosimilars Revenue Market Share by Countries
Figure United States Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure United States Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Canada Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table North America Biologics and Biosimilars Sales by Type (2016-2025) (K Units)
Table North America Biologics and Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 North America Biologics and Biosimilars Market Share by Type
Table North America Biologics and Biosimilars Sales by Application (2016-2025) (K Units)
Table North America Biologics and Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 North America Biologics and Biosimilars Market Share by Application
Table North America Biologics and Biosimilars Sales by Company (2016-2018) (K Units)
Table North America Biologics and Biosimilars Sales Market Share by Company (2016-2018)
Figure North America Biologics and Biosimilars Sales Market Share by Company in 2017
Figure Europe Biologics and Biosimilars Sales Growth Rate 2016-2025 (K Units)
Figure Europe Biologics and Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Biologics and Biosimilars Sales by Countries (2016-2025) (K Units)
Table Europe Biologics and Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Biologics and Biosimilars Sales Market Share by Countries
Table Europe Biologics and Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Europe Biologics and Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Biologics and Biosimilars Revenue Market Share by Countries
Figure Germany Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Germany Biologics and Biosimilars Revenue Growth Rate (2016-2025) (K Units)
Figure France Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure France Biologics and Biosimilars Revenue Growth Rate (2016-2025) (K Units)
Figure UK Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure UK Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Italy Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Russia Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Biologics and Biosimilars Sales by Type (2016-2025) (K Units)
Table Europe Biologics and Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Europe Biologics and Biosimilars Market Share by Type
Table Europe Biologics and Biosimilars Sales by Application (2016-2025) (K Units)
Table Europe Biologics and Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Europe Biologics and Biosimilars Market Share by Application
Table Europe Biologics and Biosimilars Sales by Company (2016-2018) (K Units)
Table Europe Biologics and Biosimilars Sales Market Share by Company (2016-2018)
Figure Europe Biologics and Biosimilars Sales Market Share by Company in 2017
Figure Asia Pacific Biologics and Biosimilars Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Biologics and Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Biologics and Biosimilars Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Biologics and Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Biologics and Biosimilars Sales Market Share by Countries
Table Asia Pacific Biologics and Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Biologics and Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Biologics and Biosimilars Revenue Market Share by Countries
Figure China Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure China Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Japan Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Korea Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure India Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure India Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Australia Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Biologics and Biosimilars Sales by Type (2016-2025) (K Units)
Table Asia Pacific Biologics and Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Biologics and Biosimilars Market Share by Type
Table Asia Pacific Biologics and Biosimilars Sales by Application (2016-2025) (K Units)
Table Asia Pacific Biologics and Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Biologics and Biosimilars Market Share by Application
Table Asia Pacific Biologics and Biosimilars Sales by Company (2016-2018) (K Units)
Table Asia Pacific Biologics and Biosimilars Sales Market Share by Company (2016-2018)
Figure Asia Pacific Biologics and Biosimilars Sales Market Share by Company in 2017
Figure Central & South America Biologics and Biosimilars Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Biologics and Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Biologics and Biosimilars Sales by Countries (2016-2025) (K Units)
Table Central & South America Biologics and Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Biologics and Biosimilars Sales Market Share by Countries
Table Central & South America Biologics and Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Biologics and Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Biologics and Biosimilars Revenue Market Share by Countries
Figure Brazil Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Biologics and Biosimilars Sales by Type (2016-2025) (K Units)
Table Central & South America Biologics and Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Biologics and Biosimilars Market Share by Type
Table Central & South America Biologics and Biosimilars Sales by Application (2016-2025) (K Units)
Table Central & South America Biologics and Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Biologics and Biosimilars Market Share by Application
Table Central & South America Biologics and Biosimilars Sales by Company (2016-2018) (K Units)
Table Central & South America Biologics and Biosimilars Sales Market Share by Company (2016-2018)
Figure Central & South America Biologics and Biosimilars Sales Market Share by Company in 2017
Figure Middle East and Africa Biologics and Biosimilars Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Biologics and Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Biologics and Biosimilars Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries
Table Middle East and Africa Biologics and Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries
Figure GCC Countries Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Biologics and Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Biologics and Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Biologics and Biosimilars Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Biologics and Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Biologics and Biosimilars Market Share by Type
Table Middle East and Africa Biologics and Biosimilars Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Biologics and Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Biologics and Biosimilars Market Share by Application
Table Middle East and Africa Biologics and Biosimilars Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Biologics and Biosimilars Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Biologics and Biosimilars Sales Market Share by Company in 2017
Table Roche Company Details
Table Roche Biologics and Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Roche Recent Development
Table Amgen Company Details
Table Amgen Biologics and Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Amgen Recent Development
Table AbbVie Company Details
Table AbbVie Biologics and Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table AbbVie Recent Development
Table Sanofi-Aventis Company Details
Table Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi-Aventis Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table Pfizer Company Details
Table Pfizer Biologics and Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novo Nordisk Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Eli Lilly Recent Development
Table Novartis Company Details
Table Novartis Biologics and Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Biologics and Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck Recent Development
Table 3sbio Company Details
Table Changchun High Tech Company Details
Table CP Guojian Company Details
Table Biotech Company Details
Table Gelgen Company Details
Table Innovent Company Details
Table Dong Bao Company Details
Table Ganlee Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Biologics and Biosimilars Value Chain
Table Typical Suppliers of Key Biologics and Biosimilars Raw Material
Table Biologics and Biosimilars Customers List
Table Biologics and Biosimilars Sales Channels
Table Biologics and Biosimilars Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *